Differences Among Older English and Spanish-speaking Latinx Patients with Type 2 Diabetes at Risk for Hypoglycemia (Admin Supp)

患有低血糖风险的老年英语和西班牙语拉丁裔 2 型糖尿病患者之间的差异(管理补充)

基本信息

  • 批准号:
    10598945
  • 负责人:
  • 金额:
    $ 8.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-15 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary Many older adults with type 2 diabetes (T2D) experience dangerous hypoglycemic due to intensive T2D medication treatment.1,2 The decision to reduce treatment intensity must be informed by patient preferences and values.3 New tools that educate patients and build their communication skills to voice their preferences offer a promising strategy for improving the safety of T2D care in high-risk older adults.4,5 The goal of this R01 award is to apply principles of values elicitation and skill building for communication and decision making to the specific clinical problem of hypoglycemia-related adverse outcomes in vulnerable older patients. The aims of the parent R01 are to develop an online tool to specifically address T2D treatment intensity in older adults at increased risk for hypoglycemic events, and to then conduct a randomized trial to assess the efficacy of this new tool to reduce hypoglycemia events among high-risk patients 75 years of age. Our approach to support value-aligned care represents an innovative and potentially widely applicable method to help older adults to make informed decisions based on their goals and preferences.6 If successful, this framework could be scaled and applied in a wide variety of healthcare settings and chronic conditions in which evolving risks, benefits, and consequences of treatment require re-assessment with age. The addition of Clarissa Ferguson through this Administrative Supplement will provide the project with the excellent opportunity to conduct analyses of older Hispanic/Latinx participants who would otherwise be eligible for our clinical trial (approximately 29% of expected participants, similar proportion to the source population in Northern California).7 She will examine the similarities and unique differences in how older Hispanic/Latinx patients with type 2 diabetes versus adults from other race/ethnicities engage with the health care system and their current medication-related practices. Further study focused on older Hispanic/Latinx patients has the potential to provide useful insight into how to best engage this patient population in research designed to improve engagement and reduce medication risk.8 The proposed research is directly related to the main goals of the parent grant while also broadening our project by extending our comparative analyses of Hispanic/Latinx patients. This study addresses the three NIH priorities of translating evidence into practice, improving medication safety, and understanding health care disparities. The specific project proposed within the Under-Represented Minority (URM) Administrative Supplement will focus on the examination of older Hispanic/Latinx patients with type 2 diabetes at increased risk for hypoglycemia. This supplemental work will provide further insight into the potential disparities and unique barriers to communication faced by older Hispanic/Latinx patients during primary care visits.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD W GRANT其他文献

RICHARD W GRANT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD W GRANT', 18)}}的其他基金

Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Prescribing in High-Risk Older Patients with Type 2 Diabetes
基于连续血糖监测的干预措施为高危老年 2 型糖尿病患者安全处方胰岛素的实用临床试验
  • 批准号:
    10559099
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
  • 批准号:
    10026740
  • 财政年份:
    2020
  • 资助金额:
    $ 8.14万
  • 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
  • 批准号:
    10237364
  • 财政年份:
    2020
  • 资助金额:
    $ 8.14万
  • 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
  • 批准号:
    10837668
  • 财政年份:
    2020
  • 资助金额:
    $ 8.14万
  • 项目类别:
Race/ethnic Differences Among Older Patients with Type 2 Diabetes at Risk for Hypoglycemia
有低血糖风险的老年 2 型糖尿病患者的种族/民族差异
  • 批准号:
    10318875
  • 财政年份:
    2020
  • 资助金额:
    $ 8.14万
  • 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
  • 批准号:
    10395599
  • 财政年份:
    2020
  • 资助金额:
    $ 8.14万
  • 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
  • 批准号:
    10633067
  • 财政年份:
    2020
  • 资助金额:
    $ 8.14万
  • 项目类别:
Administrative Supplement (PA-20-272) to Expand Safe Insulin De-Prescribing (R01 Award) to include Patients with ADRD and Their Caregivers
行政补充文件 (PA-20-272) 将安全胰岛素取消处方(R01 奖)扩大到包括 ADRD 患者及其护理人员
  • 批准号:
    10492857
  • 财政年份:
    2020
  • 资助金额:
    $ 8.14万
  • 项目类别:
Care System Analytics to Support Primary Care Patients with Complex Medical and Social Needs
护理系统分析支持具有复杂医疗和社会需求的初级保健患者
  • 批准号:
    10013216
  • 财政年份:
    2019
  • 资助金额:
    $ 8.14万
  • 项目类别:
Care System Analytics to Support Primary Care Patients with Complex Medical and Social Needs
护理系统分析支持具有复杂医疗和社会需求的初级保健患者
  • 批准号:
    10259671
  • 财政年份:
    2019
  • 资助金额:
    $ 8.14万
  • 项目类别:

相似海外基金

Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 8.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了